Journey Medical Corporation DERM Stock-Based Comp
Stock-Based Comp at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's stock-based comp?
- Journey Medical Corporation (DERM) reported stock-based comp of $989K in Q1 2026.
- How has Journey Medical Corporation's stock-based comp changed year-over-year?
- Journey Medical Corporation's stock-based comp decreased by 25.2% year-over-year, from $1.32M to $989K.
- What is the long-term trend for Journey Medical Corporation's stock-based comp?
- Over 4 years (2021 to 2025), Journey Medical Corporation's stock-based comp has grown at a 26.4% compound annual growth rate (CAGR), from $2.47M to $6.29M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.